GJA5 and metabolic syndrome: Besides down-regulation of gap junction proteins and gene expression, MetS-VLDL was found to also modulate the Cx40 and Cx43 proteins with enhanced O-GlcNAylation, which is postulated to affect the gap junction assembly and stability by interfering with the electrostatic balance on neighbor molecule interaction [82].